As of 2025-01-18, the Relative Valuation of MEI Pharma Inc (MEIP) is (102.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.87 USD, the upside of MEI Pharma Inc based on Relative Valuation is -3660.2%.
The range of the Relative Valuation is (190.33) - 60.80 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.2x - 43.0x | 34.6x |
| Forward P/E multiples | 18.4x - 29.8x | 18.6x |
| Fair Price | (190.33) - 60.80 | (102.11) |
| Upside | -6736.4% - 2020.1% | -3660.2% |
| Date | P/E |
| 2025-01-14 | -0.39 |
| 2025-01-13 | -0.39 |
| 2025-01-10 | -0.39 |
| 2025-01-08 | -0.38 |
| 2025-01-07 | -0.37 |
| 2025-01-06 | -0.38 |
| 2025-01-03 | -0.38 |
| 2025-01-02 | -0.36 |
| 2024-12-31 | -0.35 |
| 2024-12-30 | -0.35 |
| 2024-12-27 | -0.35 |
| 2024-12-26 | -0.34 |
| 2024-12-24 | -0.34 |
| 2024-12-23 | -0.34 |
| 2024-12-20 | -0.36 |
| 2024-12-19 | -0.35 |
| 2024-12-18 | -0.36 |
| 2024-12-17 | -0.37 |
| 2024-12-16 | -0.37 |
| 2024-12-13 | -0.39 |
| 2024-12-12 | -0.39 |
| 2024-12-11 | -0.39 |
| 2024-12-10 | -0.40 |
| 2024-12-09 | -0.40 |
| 2024-12-06 | -0.39 |
| 2024-12-05 | -0.39 |
| 2024-12-04 | -0.39 |
| 2024-12-03 | -0.40 |
| 2024-12-02 | -0.39 |
| 2024-11-29 | -0.40 |
| 2024-11-27 | -0.40 |
| 2024-11-26 | -0.41 |
| 2024-11-25 | -0.39 |
| 2024-11-22 | -0.40 |
| 2024-11-21 | -0.40 |
| 2024-11-20 | -0.40 |
| 2024-11-19 | -0.41 |
| 2024-11-18 | -0.41 |
| 2024-11-15 | -0.42 |
| 2024-11-14 | -0.43 |
| 2024-11-13 | -0.43 |
| 2024-11-12 | -0.45 |
| 2024-11-11 | -0.45 |
| 2024-11-08 | -0.43 |
| 2024-11-07 | -0.43 |
| 2024-11-06 | -0.43 |
| 2024-11-05 | -0.43 |
| 2024-11-04 | -0.44 |
| 2024-11-01 | -0.44 |
| 2024-10-31 | -0.44 |